Concepts (205)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Wake Disorders | 3 | 2024 | 373 | 1.250 |
Why?
|
| Sleep Apnea, Obstructive | 3 | 2024 | 261 | 1.170 |
Why?
|
| Polysomnography | 4 | 2024 | 176 | 1.050 |
Why?
|
| Bronchiolitis Obliterans | 4 | 2024 | 94 | 0.710 |
Why?
|
| Bronchoscopy | 5 | 2019 | 482 | 0.700 |
Why?
|
| Pleural Effusion, Malignant | 5 | 2021 | 160 | 0.640 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2024 | 864 | 0.620 |
Why?
|
| Blood Loss, Surgical | 1 | 2019 | 294 | 0.600 |
Why?
|
| Hematologic Neoplasms | 5 | 2020 | 1951 | 0.540 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 10 | 2024 | 7011 | 0.540 |
Why?
|
| Catheters, Indwelling | 6 | 2020 | 383 | 0.470 |
Why?
|
| Thrombocytopenia | 1 | 2019 | 872 | 0.460 |
Why?
|
| Thoracentesis | 4 | 2020 | 61 | 0.420 |
Why?
|
| Lung Diseases | 1 | 2017 | 755 | 0.380 |
Why?
|
| Leukemia | 2 | 2017 | 1721 | 0.380 |
Why?
|
| Disorders of Excessive Somnolence | 2 | 2021 | 38 | 0.370 |
Why?
|
| Graft vs Host Disease | 5 | 2023 | 2809 | 0.350 |
Why?
|
| Neoplasms | 8 | 2023 | 15903 | 0.320 |
Why?
|
| Pleura | 3 | 2020 | 130 | 0.320 |
Why?
|
| Lymphoma | 1 | 2017 | 1524 | 0.310 |
Why?
|
| Solitary Pulmonary Nodule | 2 | 2020 | 125 | 0.300 |
Why?
|
| Bronchiolitis | 1 | 2007 | 131 | 0.270 |
Why?
|
| Respiratory Tract Infections | 3 | 2019 | 408 | 0.260 |
Why?
|
| Respiratory Function Tests | 3 | 2024 | 355 | 0.260 |
Why?
|
| Pleural Effusion | 2 | 2020 | 218 | 0.250 |
Why?
|
| Respiratory Syncytial Virus Infections | 2 | 2019 | 434 | 0.240 |
Why?
|
| Retrospective Studies | 17 | 2024 | 39818 | 0.230 |
Why?
|
| Lung | 5 | 2023 | 3300 | 0.230 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2007 | 567 | 0.230 |
Why?
|
| Exudates and Transudates | 2 | 2021 | 57 | 0.220 |
Why?
|
| Pleurodesis | 3 | 2020 | 70 | 0.210 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2021 | 270 | 0.210 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2024 | 140 | 0.210 |
Why?
|
| Middle Aged | 25 | 2024 | 90422 | 0.210 |
Why?
|
| Breast Neoplasms | 2 | 2024 | 16221 | 0.200 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2022 | 62 | 0.200 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2022 | 60 | 0.190 |
Why?
|
| Adult | 19 | 2024 | 82003 | 0.190 |
Why?
|
| Humans | 45 | 2024 | 271550 | 0.190 |
Why?
|
| Aged | 19 | 2024 | 73451 | 0.190 |
Why?
|
| Transplant Recipients | 2 | 2020 | 337 | 0.190 |
Why?
|
| Vital Capacity | 1 | 2021 | 139 | 0.180 |
Why?
|
| Female | 26 | 2024 | 149106 | 0.170 |
Why?
|
| Forced Expiratory Volume | 1 | 2021 | 327 | 0.170 |
Why?
|
| Pneumothorax | 1 | 2020 | 166 | 0.160 |
Why?
|
| Head and Neck Neoplasms | 1 | 2014 | 4139 | 0.160 |
Why?
|
| Platelet Transfusion | 1 | 2019 | 168 | 0.160 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2022 | 277 | 0.160 |
Why?
|
| Lung Transplantation | 1 | 2023 | 386 | 0.160 |
Why?
|
| Advance Care Planning | 1 | 2019 | 94 | 0.150 |
Why?
|
| Tracheostomy | 1 | 2021 | 248 | 0.150 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2018 | 87 | 0.150 |
Why?
|
| Respiratory Insufficiency | 1 | 2021 | 346 | 0.150 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2018 | 173 | 0.150 |
Why?
|
| Device Removal | 1 | 2020 | 338 | 0.150 |
Why?
|
| Cryptococcosis | 1 | 2017 | 70 | 0.140 |
Why?
|
| Male | 25 | 2024 | 128724 | 0.140 |
Why?
|
| Airway Obstruction | 2 | 2014 | 272 | 0.140 |
Why?
|
| Lung Diseases, Fungal | 1 | 2017 | 133 | 0.140 |
Why?
|
| Pleural Neoplasms | 1 | 2021 | 487 | 0.140 |
Why?
|
| Tongue Neoplasms | 1 | 2018 | 253 | 0.140 |
Why?
|
| Biopsy, Needle | 1 | 2020 | 1401 | 0.140 |
Why?
|
| Pleural Cavity | 2 | 2014 | 26 | 0.140 |
Why?
|
| Mesothelioma | 1 | 2021 | 560 | 0.130 |
Why?
|
| Aged, 80 and over | 9 | 2021 | 31066 | 0.130 |
Why?
|
| Pneumonia | 2 | 2021 | 798 | 0.130 |
Why?
|
| Hemothorax | 1 | 2015 | 30 | 0.130 |
Why?
|
| Drainage | 4 | 2020 | 451 | 0.130 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2019 | 261 | 0.130 |
Why?
|
| Iatrogenic Disease | 1 | 2016 | 197 | 0.120 |
Why?
|
| Tracheitis | 1 | 2014 | 21 | 0.120 |
Why?
|
| Vocal Cord Paralysis | 1 | 2016 | 94 | 0.120 |
Why?
|
| Cytokines | 2 | 2023 | 2825 | 0.120 |
Why?
|
| Transplantation Conditioning | 3 | 2020 | 2367 | 0.120 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2014 | 85 | 0.120 |
Why?
|
| Voriconazole | 1 | 2014 | 115 | 0.120 |
Why?
|
| Young Adult | 8 | 2020 | 22190 | 0.110 |
Why?
|
| Bronchial Neoplasms | 1 | 2014 | 83 | 0.110 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2021 | 3148 | 0.110 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2015 | 166 | 0.110 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2014 | 80 | 0.110 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 1062 | 0.110 |
Why?
|
| Sarcoma, Myeloid | 1 | 2014 | 94 | 0.110 |
Why?
|
| Incidence | 3 | 2019 | 5848 | 0.110 |
Why?
|
| Risk Factors | 6 | 2022 | 17982 | 0.110 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2014 | 236 | 0.110 |
Why?
|
| Fatigue | 2 | 2021 | 1279 | 0.110 |
Why?
|
| Immunocompromised Host | 4 | 2019 | 720 | 0.110 |
Why?
|
| Piperidines | 2 | 2017 | 1087 | 0.100 |
Why?
|
| Equipment and Supplies | 1 | 2012 | 51 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2024 | 7792 | 0.100 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2017 | 749 | 0.100 |
Why?
|
| Logistic Models | 2 | 2019 | 3455 | 0.100 |
Why?
|
| Electronic Health Records | 1 | 2019 | 973 | 0.100 |
Why?
|
| Nervous System Diseases | 1 | 2015 | 519 | 0.090 |
Why?
|
| Pericarditis | 1 | 2011 | 61 | 0.090 |
Why?
|
| Hemorrhage | 2 | 2022 | 741 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 2390 | 0.080 |
Why?
|
| Anemia | 1 | 2015 | 728 | 0.080 |
Why?
|
| Quinazolines | 1 | 2014 | 956 | 0.080 |
Why?
|
| Multiple Myeloma | 1 | 2020 | 2287 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 4380 | 0.080 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2011 | 215 | 0.080 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 3942 | 0.080 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2021 | 7262 | 0.070 |
Why?
|
| Bronchoalveolar Lavage | 2 | 2023 | 55 | 0.070 |
Why?
|
| Administration, Inhalation | 1 | 2007 | 299 | 0.070 |
Why?
|
| Transplantation, Homologous | 3 | 2022 | 3056 | 0.070 |
Why?
|
| Lung Neoplasms | 3 | 2020 | 12032 | 0.070 |
Why?
|
| Pulmonary Alveoli | 1 | 2007 | 223 | 0.070 |
Why?
|
| Adolescent | 4 | 2020 | 32726 | 0.060 |
Why?
|
| Feasibility Studies | 2 | 2021 | 2364 | 0.060 |
Why?
|
| Sarcoma | 1 | 2015 | 1840 | 0.060 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2004 | 49 | 0.060 |
Why?
|
| Nasopharynx | 1 | 2023 | 117 | 0.050 |
Why?
|
| Early Diagnosis | 1 | 2024 | 316 | 0.050 |
Why?
|
| Survival Rate | 4 | 2018 | 12528 | 0.050 |
Why?
|
| Radiography, Thoracic | 2 | 2015 | 478 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 5606 | 0.050 |
Why?
|
| Protamines | 1 | 2022 | 29 | 0.050 |
Why?
|
| Respiratory Mucosa | 1 | 2004 | 211 | 0.050 |
Why?
|
| Antidotes | 1 | 2022 | 27 | 0.050 |
Why?
|
| Neutropenia | 2 | 2018 | 1001 | 0.050 |
Why?
|
| Vitamin K | 1 | 2022 | 54 | 0.050 |
Why?
|
| Dyspnea | 2 | 2015 | 420 | 0.050 |
Why?
|
| Aftercare | 1 | 2023 | 253 | 0.050 |
Why?
|
| Gelatin | 1 | 2021 | 43 | 0.050 |
Why?
|
| Antineoplastic Agents | 3 | 2020 | 14631 | 0.050 |
Why?
|
| Positron Emission Tomography Computed Tomography | 2 | 2017 | 880 | 0.050 |
Why?
|
| Suction | 1 | 2020 | 112 | 0.050 |
Why?
|
| Prospective Studies | 3 | 2023 | 13385 | 0.040 |
Why?
|
| Spirometry | 1 | 2020 | 153 | 0.040 |
Why?
|
| Endocrine System | 1 | 2020 | 37 | 0.040 |
Why?
|
| Azithromycin | 1 | 2020 | 79 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2007 | 1421 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2004 | 788 | 0.040 |
Why?
|
| Antilymphocyte Serum | 1 | 2020 | 237 | 0.040 |
Why?
|
| Vacuum | 1 | 2019 | 44 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2019 | 9477 | 0.040 |
Why?
|
| Recurrence | 2 | 2020 | 4882 | 0.040 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2012 | 2911 | 0.040 |
Why?
|
| Sample Size | 1 | 2019 | 214 | 0.040 |
Why?
|
| Unrelated Donors | 1 | 2020 | 321 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2023 | 706 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 4955 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2022 | 1620 | 0.040 |
Why?
|
| Sleep | 1 | 2021 | 443 | 0.040 |
Why?
|
| Treatment Outcome | 5 | 2020 | 33870 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 5566 | 0.030 |
Why?
|
| Maintenance Chemotherapy | 1 | 2017 | 224 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2022 | 787 | 0.030 |
Why?
|
| Lymphopenia | 1 | 2018 | 211 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2021 | 1731 | 0.030 |
Why?
|
| Respiratory Sounds | 1 | 2016 | 93 | 0.030 |
Why?
|
| Asthma | 1 | 2004 | 895 | 0.030 |
Why?
|
| Patient Participation | 1 | 2019 | 456 | 0.030 |
Why?
|
| Bacteria | 1 | 2019 | 654 | 0.030 |
Why?
|
| Cryotherapy | 1 | 2014 | 67 | 0.030 |
Why?
|
| Skin | 1 | 2020 | 1281 | 0.030 |
Why?
|
| Adenine | 1 | 2017 | 669 | 0.030 |
Why?
|
| Intracranial Pressure | 1 | 2015 | 197 | 0.030 |
Why?
|
| Hospitalization | 1 | 2023 | 2180 | 0.030 |
Why?
|
| Aspergillus | 1 | 2014 | 151 | 0.030 |
Why?
|
| Time Factors | 2 | 2020 | 13077 | 0.030 |
Why?
|
| Communication | 1 | 2019 | 855 | 0.030 |
Why?
|
| Inflammation | 1 | 2023 | 2531 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 920 | 0.030 |
Why?
|
| Survivors | 1 | 2018 | 1023 | 0.030 |
Why?
|
| Necrosis | 1 | 2014 | 602 | 0.030 |
Why?
|
| Steroids | 1 | 2014 | 370 | 0.030 |
Why?
|
| Biomarkers | 1 | 2004 | 5086 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2015 | 583 | 0.030 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2014 | 362 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2019 | 1261 | 0.020 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2021 | 1335 | 0.020 |
Why?
|
| Quality Control | 1 | 2012 | 466 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2014 | 467 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 6205 | 0.020 |
Why?
|
| Acute Disease | 1 | 2014 | 2501 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2017 | 1540 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2015 | 1935 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 2014 | 876 | 0.020 |
Why?
|
| Patient Safety | 1 | 2012 | 657 | 0.020 |
Why?
|
| Texas | 1 | 2017 | 6444 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2011 | 1279 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2017 | 9307 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2017 | 3662 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6264 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 2007 | 582 | 0.010 |
Why?
|
| Interleukin-13 | 1 | 2004 | 130 | 0.010 |
Why?
|
| Aspergillus fumigatus | 1 | 2004 | 136 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 2004 | 182 | 0.010 |
Why?
|
| Algorithms | 1 | 2014 | 3925 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 14015 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2007 | 2048 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 4961 | 0.010 |
Why?
|
| Allergens | 1 | 2004 | 252 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2017 | 5697 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 1527 | 0.010 |
Why?
|
| Quality of Life | 1 | 2014 | 4764 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2004 | 2462 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2004 | 3610 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2004 | 6234 | 0.010 |
Why?
|
| Mice | 1 | 2004 | 35697 | 0.000 |
Why?
|
| Animals | 1 | 2004 | 62359 | 0.000 |
Why?
|